Tilray | Ventes



Sales Changement Date
Acasti Pharma USD -4760000 4.76M 2024-12
Alaunos Therapeutics USD 0 4K 2024-09
Aurora Cannabis CAD 88.2M 7.08M 2024-12
Avita Medical AUD 18.41M 7.89M 2024-12
Canopy Growth CAD 74.76M 11.77M 2024-12
Cronos Group USD 33.46M 160K 2025-06
Dianthus Therapeutics USD 1.33M 846K 2024-12
Divis Laboratories Ltd 24.1B 1.75B 2025-06
Ionis Pharmaceuticals USD 452M 320M 2025-06
IQVIA Holdings USD 4.02B 190M 2025-06
Knight Therapeutics CAD 92.26M 3.31M 2024-09
Moderna USD 142M 34M 2025-06
Organigram Holdings CAD 42.73M 1.97M 2024-12
Organon & Co 1.59B 80M 2025-06
Revvity USD 720M 55M 2025-06
Tectonic Therapeutic 0 0 2024-12
Tilray USD 308.01M 43.78M 2025-06
Viatris USD 3.57B 320M 2025-06
Xeris Pharmaceuticals USD 60.1M 5.83M 2024-12


Tilray Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.